Published online Aug 15, 2025. doi: 10.4251/wjgo.v17.i8.108016
Revised: May 28, 2025
Accepted: July 2, 2025
Published online: August 15, 2025
Processing time: 120 Days and 15.6 Hours
Serum carcinoembryonic antigen (CEA) levels and magnetic resonance imaging (MRI) findings are widely used for the diagnosis and treatment of rectal cancer; however, research investigating their correlation remains limited.
To investigate the correlation between baseline MRI features and serum CEA levels in patients diagnosed with primary rectal cancer.
Eighty patients (age: 42-78 years) diagnosed with primary rectal cancer were enrolled. Baseline MRI examinations were performed to evaluate tumor size, T stage, circumferential resection margin status, extramural vascular invasion (EMVI), and lymph node metastasis. Serum CEA levels were concurrently measured. Statistical methods were used to analyze correlations.
Tumor size, T stage, EMVI, and lymph node metastasis were significantly correlated with serum CEA levels (P < 0.05). Multivariate analysis identified T stage and lymph node metastasis as independent factors influencing serum CEA levels.
This study confirmed the correlation between baseline MRI features and serum CEA levels in patients with primary rectal cancer, highlighting their potential utility for precise diagnosis, staging, and prognostic evaluation.
Core Tip: The correlation between magnetic resonance imaging (MRI) features and serum carcinoembryonic antigen (CEA) levels for diagnosing and treating rectal cancer currently remains under investigation. Accordingly, the present study explored this association in 80 patients diagnosed with primary rectal cancer at the authors’ hospital between July 2022 and August 2024. Patients were grouped according to clinical characteristics and treatment plans, and analysis confirmed a strong correlation between baseline MRI features and serum CEA levels.